These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1616 related articles for article (PubMed ID: 28652656)

  • 101. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease-Possible biomarker for evaluating mucosal healing.
    Ishihara S; Tada Y; Kawashima K; Kataoka M; Sonoyama H; Yamashita N; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kinoshita Y
    Dig Liver Dis; 2018 Jun; 50(6):553-558. PubMed ID: 29311027
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis.
    Planell N; Masamunt MC; Leal RF; Rodríguez L; Esteller M; Lozano JJ; Ramírez A; Ayrizono MLS; Coy CSR; Alfaro I; Ordás I; Visvanathan S; Ricart E; Guardiola J; Panés J; Salas A
    J Crohns Colitis; 2017 Oct; 11(11):1335-1346. PubMed ID: 28981629
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
    Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
    BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
    Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?
    Koek GH; Verleden GM; Evenepoel P; Rutgeerts P
    Respir Med; 2002 Jul; 96(7):530-5. PubMed ID: 12194639
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [TBL] [Abstract][Full Text] [Related]  

  • 110. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.
    Wang J; Ortiz C; Fontenot L; Xie Y; Ho W; Mattai SA; Shih DQ; Koon HW
    PLoS One; 2020; 15(4):e0231796. PubMed ID: 32287314
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Reduced Transferrin Levels in Active Inflammatory Bowel Disease.
    Matusiewicz M; Neubauer K; Lewandowska P; Gamian A; Krzystek-Korpacka M
    Biomed Res Int; 2017; 2017():9541370. PubMed ID: 29226154
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
    Alsoud D; Ho J; Sabino J; Ferrante M; Vermeire S; Verstockt B
    Am J Gastroenterol; 2024 Mar; 119(3):477-485. PubMed ID: 37753938
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Correlations Between the Expression of MicroRNA-155 and Suppressor of Cytokine Signaling 1 in Colonic Mucosal Tissue and Disease Severity in Patients With Ulcerative Colitis].
    Zhang X; Jia HY; Song WX; Zhao HQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Jun; 46(3):334-340. PubMed ID: 38953257
    [TBL] [Abstract][Full Text] [Related]  

  • 114. RNA methylation machinery and m
    Motawi TK; Shaker OG; Amr G; Senousy MA
    Clin Chim Acta; 2024 Jul; 561():119831. PubMed ID: 38925436
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
    Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
    Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease.
    Leach ST; Messina I; Lemberg DA; Novick D; Rubenstein M; Day AS
    Inflamm Bowel Dis; 2008 Jan; 14(1):68-74. PubMed ID: 17879274
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
    Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
    Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease.
    Holtkamp W; Stollberg T; Reis HE
    J Clin Gastroenterol; 1995 Mar; 20(2):123-6. PubMed ID: 7769191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.